Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hanzhong Chen
Observed name:
H. Chen
Institutions:
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Southern Medical University
Observed institutions:
Guangdong General Hospital,
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Southern Medical University
ORCID:
0009-0004-6286-5082
Observed ORCID:
0009-0004-6286-5082
OpenAlex ID:
A5041062721
22P Adding anlotinib in gradual or local progression on first-line EGFR-TKIs for advanced non-small cell lung cancer: A single-arm, multicenter, phase II trial
2023
·
H. Chen
, Y. Hu
, et al.
·
Journal of Thoracic Oncology
·
2
PDF
Engineered prostate-specific membrane antigen-targeted liposomal nanoplatform integrating near-infrared fluorescence, ultrasound, and magnetic resonance imaging for precision prostate cancer imaging
2026
·
Kunlin Wu
, Zhiye Liu
, et al.
·
Materials & Design
·
1
Severe exfoliative dermatitis induced by apalutamide in a mHSPC patient: A case report
2026
·
Hanzhong Chen
, Teng Li
, et al.
·
Medicine
·
1
A Phase || Trial of First-Line Nab-Paclitaxel/Carboplatin Versus Gemcitabine/Carboplatin in Advanced Squamous Cell Carcinoma of the Lung (Ctong1002)
2014
·
J. Yang
, C. Huang
, et al.
·
Annals of Oncology
·
1
Development and external validation of nomograms for predicting prostate cancer and clinically significant prostate cancer in patients with PSA between 4 and 20 ng/mL
2026
·
Kunlin Wu
, Chujin Ye
, et al.
·
BMC Urology
385P Efficacy and safety of pyrotinib in untreated, advanced non-small cell lung cancer with HER2 mutations: A parallel, multi-center, multi-cohort patient-centric study (CTONG1702 and 1705)
2022
·
S-Y.M. Liu
, H-Y. Tu
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
6
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type